908 Devices Inc.

NASDAQ: MASS · Real-Time Price · USD
5.38
-0.05 (-0.92%)
At close: May 01, 2025, 3:59 PM
5.28
-1.86%
After-hours: May 01, 2025, 06:38 PM EDT

Company Description

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets.

The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis.

It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.

908 Devices Inc.
908 Devices Inc. logo
Country United States
IPO Date Dec 18, 2020
Industry Medical - Devices
Sector Healthcare
Employees 246
CEO Joseph H. Griffith IV

Contact Details

Address:
645 Summer Street
Boston, Massachusetts
United States
Website https://www.908devices.com

Stock Details

Ticker Symbol MASS
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001555279
CUSIP Number 65443P102
ISIN Number US65443P1021
Employer ID 45-4524096
SIC Code 3829

Key Executives

Name Position
Joseph H. Griffith IV Chief Financial Officer & Treasurer
Dr. Christopher David Brown Ph.D. Co-Founder & Board Advisor
Michael S. Turner Esq., J.D. Chief Legal & Administrative Officer and Secretary

Latest SEC Filings

Date Type Title
Apr 28, 2025 ARS Filing
Apr 28, 2025 DEFA14A Filing
Apr 28, 2025 DEF 14A Filing
Apr 25, 2025 SCHEDULE 13G/A [Amend] Filing
Apr 07, 2025 SCHEDULE 13G Filing
Mar 14, 2025 3 Filing
Mar 07, 2025 8-K/A [Amend] Current Report
Mar 07, 2025 S-8 Filing
Mar 07, 2025 10-K Annual Report
Mar 05, 2025 4 Filing